Early detection of breast cancer increases the chances of cure, but the reliable identification of impalpable lesions is still a challenge. In spite of the advances in breast cancer detection, the molecular basis of impalpable lesions and the corresponding circulating biomarkers are not well understood. Impalpable lesions, classified by radiologists according to the Breast Imaging Reporting and Data System in the categories 3 and 4, can be either benign or malignant (slow growing or aggressive). In this article, we report the DNA methylation pattern in CDKN2A (p14(ARF)/p16(INK4a)) and in ATM gene promoters from 62 impalpable lesions, 39 peripheral blood samples, and 39 saliva samples, assessed by methylation-specific polymerase chain reaction method. ATM showed the greatest percentage of methylation in DNA from lesions (benign and malignant), blood (even with p16(INK4a)), and saliva, followed by p16(INK4a) and p14(ARF). Among the malignant cases, ATM promoter was the most hypermethylated in lesion DNA and in blood and saliva DNAs, and p14(ARF), the least. The highest percentage of p16(INK4a) methylation was found in the blood. Finally, our data are relevant because they were obtained using impalpable breast lesions from patients who were carefully recruited in 2 public hospitals of Rio de Janeiro.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.humpath.2015.06.016 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
SCOUT® radar reflectors for impalpable lesion localisation in the breast and axilla: our experience in the first 500 patients.
Clin Radiol
December 2024
Royal Liverpool University Hospital, Breast Radiology Unit, Liverpool, UK.
Aim: This study aimed to detail our experience of using SCOUT® radar reflector for lesion localisation in the breast and axilla.
Materials And Methods: This is a prospective cohort study describing our clinical experience with the first 500 patients who received SCOUT® to localise lesions in the breast and axilla (from 23 July 2020 to 4 April 2022). Study measures include patient demographics, lesion location, diagnostic pathways (screening or symptomatic), imaging, and surgical and pathology outcomes.
Preoperative Ultrasound-Guided Marking, Mammogram, and Peroperative Use of Image Intensifier: A Cost-Effective Technique in Clipped Non-Palpable Breast Cancer Lesions to Achieve Adequate Surgical Margins.
J Coll Physicians Surg Pak
November 2024
Department of Breast Surgery, Ittefaq Hospital (Trust), Lahore, Pakistan.
Objective: To measure the effectiveness of localisation and removal of impalpable target lesions without compromising patient safety in a resource-limited setup using preoperative ultrasound and mammography with peroperative use of C-arm image intensifier.
Study Design: Descriptive study. Place and Duration of the Study: Department of Breast Surgery, Ittefaq Hospital (Trust), Lahore, Pakistan, from 25th October 2011 to 17th February 2023.
Radiofrequency as a method of localizing impalpable breast lesions.
Surgeon
October 2024
Walsall Healthcare NHS Trust, UK. Electronic address:
Article Synopsis
- More women are being diagnosed with early stage breast cancer because of better screening techniques and public awareness.
- A new device called LOCalizerTM helps doctors accurately find and treat tiny tumors that can’t be felt.
- The study looked at how effective this device is in helping patients have successful surgeries and avoid needing extra operations later.
Results of shared learning of a new radiofrequency identification localization device-a UK iBRA-NET breast cancer localisation study.
Clin Radiol
November 2024
Nightingale Breast Centre, Manchester University NHS Foundation Trust, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. Electronic address:
Introduction: Localisation methods for surgical excision of impalpable breast lesions have advanced in recent years, with increasing utilization of new wire-free technologies. The Hologic LOCalizer™ radiofrequency identification (RFID) tag is one such device; however, as is the case when new technologies are first introduced, little is known about clinical experiences, potential complications, and learning used to overcome perioperative challenges when changing from guidewires to RFID tags. This study reports shared learning experiences of clinicians using the LOCalizer™ as part of the national iBRA-NET localisation study.
View Article and Find Full Text PDFRadioactive Seed Localization for Nonpalpable Breast Lesions: Systematic Review and Meta-Analysis.
Diagnostics (Basel)
February 2024
Nuclear and Energy Research Institute (IPEN/CNEN-SP), University of São Paulo (USP), Av. Professor Lineu Prestes 2242, São Paulo 05508-000, SP, Brazil.
Background: This study is a systematic review with meta-analysis comparing radioactive seed localization (RSL) versus radio-guided occult lesion localization (ROLL) and wire-guided localization (WGL) for patients with impalpable breast cancer undergoing breast-conserving surgery and evaluating efficacy, safety, and logistical outcomes. The protocol is registered in PROSPERO with the number CRD42022299726.
Methods: A search was conducted in the Embase, Lilacs, Pubmed, Scielo, Web of Science, and clinicaltrials.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!